Literature DB >> 21333898

The effect of irritable bowel syndrome on health-related quality of life and health care expenditures.

Nikhil Agarwal1, Brennan M R Spiegel.   

Abstract

Irritable bowel syndrome (IBS) is a highly prevalent condition with a large health economic burden of illness marked by impaired health-related quality of life (HRQOL), diminished work productivity, and high expenditures. Clinicians should routinely screen for diminished HRQOL by performing a balanced biopsychosocial history rather than focusing just on bowel symptoms. HRQOL decrements should be acknowledged and addressed when making treatment decisions. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2011        PMID: 21333898     DOI: 10.1016/j.gtc.2010.12.013

Source DB:  PubMed          Journal:  Gastroenterol Clin North Am        ISSN: 0889-8553            Impact factor:   3.806


  44 in total

Review 1.  Food allergy in irritable bowel syndrome: The case of non-celiac wheat sensitivity.

Authors:  Pasquale Mansueto; Alberto D'Alcamo; Aurelio Seidita; Antonio Carroccio
Journal:  World J Gastroenterol       Date:  2015-06-21       Impact factor: 5.742

2.  Symptom Comparisons Between Asian American and White American Women With Irritable Bowel Syndrome.

Authors:  Claire Jungyoun Han; Chaoqun Dong; Monica E Jarrett; Margaret M Heitkemper
Journal:  Gastroenterol Nurs       Date:  2018 May/Jun       Impact factor: 0.978

3.  The combination of oligo- and polysaccharides and reticulated protein for the control of symptoms in patients with irritable bowel syndrome: Results of a randomised, placebo-controlled, double-blind, parallel group, multicentre clinical trial.

Authors:  Octavian Alexea; Vlad Bacarea; Núria Piqué
Journal:  United European Gastroenterol J       Date:  2015-10-30       Impact factor: 4.623

4.  A preliminary evaluation of comparative effectiveness of riluzole in therapeutic regimen for irritable bowel syndrome.

Authors:  Surya Prakash Mishra; Sunit Kumar Shukla; Bajrang Lal Pandey
Journal:  Asian Pac J Trop Biomed       Date:  2014-05

5.  Neuroimaging the brain-gut axis in patients with irritable bowel syndrome.

Authors:  Kristen R Weaver; LeeAnne B Sherwin; Brian Walitt; Gail D'Eramo Melkus; Wendy A Henderson
Journal:  World J Gastrointest Pharmacol Ther       Date:  2016-05-06

6.  Age-related symptom and life quality changes in women with irritable bowel syndrome.

Authors:  Yu-Rong Tang; Wei-Wei Yang; Mei-Lan Liang; Xin-Yu Xu; Mei-Feng Wang; Lin Lin
Journal:  World J Gastroenterol       Date:  2012-12-28       Impact factor: 5.742

7.  Treatment of Dientamoeba fragilis in patients with irritable bowel syndrome.

Authors:  Anne Line Engsbro; C Rune Stensvold; Henrik V Nielsen; Peter Bytzer
Journal:  Am J Trop Med Hyg       Date:  2012-10-22       Impact factor: 2.345

8.  Associations among gut permeability, inflammatory markers, and symptoms in patients with irritable bowel syndrome.

Authors:  Robert J Shulman; Monica E Jarrett; Kevin C Cain; Elizabeth K Broussard; Margaret M Heitkemper
Journal:  J Gastroenterol       Date:  2014-01-17       Impact factor: 7.527

Review 9.  Role of antispasmodics in the treatment of irritable bowel syndrome.

Authors:  Anita Annaházi; Richárd Róka; András Rosztóczy; Tibor Wittmann
Journal:  World J Gastroenterol       Date:  2014-05-28       Impact factor: 5.742

Review 10.  Managing irritable bowel syndrome.

Authors:  Joyce K Anastasi; Bernadette Capili; Michelle Chang
Journal:  Am J Nurs       Date:  2013-07       Impact factor: 2.220

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.